Teng HJ#, Wang Y#, Sui X#, Fan JW, Li S, Lei X, Shi C, Sun W, Song MXW, Wang HZ, Dong DZ, Geng JH, Zhang YZ, Zhu XG, Cai Y, Li YH, Li B, Min QJ, Wang WH*, Zhan QM*. Gut microbiota-mediated nucleotide synthesis attenuates the response to neoadjuvant chemoradiotherapy in rectal cancer.,Cancer Cell,2023,41(1):124-138

Chen B, Wu JX, Cheng SH, Wang LM, Rong WQ, Wu F, Wang SL, Jin J, Liu YP, Song YW, Ren H, Fang H, Tang Y, Li N, Li YX*, Wang WH*. Phase 2 study of adjuvant radiotherapy following narrow-margin hepatectomy in patients with HCC,Hepatology,74(5): 2595-2604

Wu F#, Chen B#, Dong D#, Rong W#, Wang H, Wang L, Wang S, Jin J, Song Y, Liu Y, Fang H, Tang Y, Li N, Zhu X, Li Y, Wu J*, Wang W*. Phase 2 Evaluation of Neoadjuvant Intensity-Modulated Radiotherapy in Centrally Located Hepatocellular Carcinoma: A Nonrandomized Controlled Trial.,JAMA Surg,2022 Oct 5;e224702.

Zhang Y, Song M, Geng J, Zhu X, Li S, Li Y, Cai Y*, Wang W*. Patterns of failure and implications for clinical target volume definition of locally advanced T4b rectal cancer identified with magnetic resonance imaging and treated using neoadjuvant chemoradiotherapy and surgery,Radiotherapy and Oncology,2021;161:132-139

Long L#, Chen B#, Wang H#, Zhao Y#, Wu F, Wang L, Rong W, Wu J, Li Y*, Wang W*. Survival benefit of radiotherapy following narrow-margin hepatectomy in patients with hepatocellular carcinoma: A propensity score-matched analysis based on phase II study,Radiotherapy and Oncology,2023 Mar;180:109462

Song M#, Li S#, Wang H#, Hu K, Wang F, Teng H, Wang Z, Liu J, Jia AY, Cai Y, Li Y, Zhu X, Geng J, Zhang Y, Wan X, Wang W*. MRI radiomics independent of clinical baseline characteristics and neoadjuvant treatment modalities predicts response to neoadjuvant therapy in rectal cancer.,Br J Cancer,2022;127(2):249-257

Wang L#, Zhang XY#, Zhao YM#, Li SJ, Li ZW, Sun YS, Wang WH*, Wu AW*; Rectal Cancer Cooperative Group of Peking University Cancer Hospital. Intentional Watch & Wait or Organ Preservation Surgery Following Neoadjuvant Chemoradiotherapy Plus Consolidation CAPEOX for MRI-defined Low-risk Rectal Cancer: Findings from a Prospective Phase 2 Trial (PKUCH-R01 Trial, NCT02860234).,Ann Surg,2022 Jun 29. doi: 10.1097/SLA.0000000000005507. Online ahead of print.

Wan M, Zhao D, Liu W, Huang Z, Xu X, Zheng B, Xiao S, Sun Y, Wang W. Pretherapy platelet-to-lymphocyte ratio as a prognostic parameter for locally advanced hypopharyngeal cancer patients treated with radiotherapy combined with chemotherapy.,Eur Arch Otorhinolaryngol.,2022 Dec;279(12):5859-5868

Sheng XQ, Wang HZ, Li S, Zhang YZ, Geng JH, Zhu XG, Quan JZ, Li YH, Cai Y, Wang WH*. Consolidation chemotherapy with capecitabine after neoadjuvant chemoradiotherapy in high-risk patients with locally advanced rectal cancer: Propensity score study. World J Gastrointest Oncol.,World Journal of Gastrointestinal Oncology,2022 Sep 15;14(9):1711-1726.

Wang H, Zhu X, Zhao Y, Dong D, Li L, Cai Y, Li Y, Wang W. Phase 1 trial of apatinib combined with intensity-modulated radiotherapy in unresectable hepatocellular carcinoma.,BMC Cancer,2022 Jul 15;22(1):771.

Jiao Ming, Rongxu Du, Jianhao Geng, Shuai Li, Zhiyan Liu, Yong Cai, Xianggao Zhu, Yangzi Zhang, Hongzhi Wang, Zhilong Wang, Lei Tang, Xiaotian Zhang, Zhi Peng, Aiwen Wu, Zhaode Bu, Yifan Peng, Yan Yan, Zhongwu Li, Yongheng Li*, Ziyu Li* and Weihu Wang* Prognostic impact of sarcopenia in patients with locally advanced adenocarcinoma of the esophagogastric junction treated with neoadjuvant chemoradiotherapy,Frontiers in nutrition,10卷，期不详，988632页

Wan M, Zhao D, Sun Y, Wang W. A Novel Overall Survival Nomogram Prediction of Secondary Primary Malignancies after Hypopharyngeal Cancer: A Population-Based Study.,J Oncology,2022 Apr 28;2022:4681794.

Dong D#, Zhao D#, Li S, Liu W, Du F, Xu X, Xiao S, Zheng B, Sun Y*, Wang W*. Nomogram to predict overall survival for patients with non- metastatic cervical esophageal cancer: a SEER-based population study,Annals of Translational Medicine,2020; 8(23): 1588

Sheng X#, Li S#, Zhang Y, Geng J, Wang H, Zhu X, Quan J, Li Y, Cai Y*, Wang W*. One to Two Cycles of Consolidation Chemotherapy With Capecitabine After Neoadjuvant Chemoradiotherapy Does Not Benefit Low-Risk Patients With Locally Advanced Middle-Low Rectal Cancer.,Front Oncol,2021; 11:695726.

Wan M#, Zhao D#, Liu W, Xu X, Zheng B, Xiao S, Sun Y*, Wang W*. Clinical characteristics and prognosis of patients with hypopharyngeal cancers with multiple primary cancers: A propensity score matched analysis.,Am J Otolaryngol,2021;43(2):103297

Dong D#, Zhu X#, Wang H#, Li L, Wan M, Li S, Zhang Y, Geng J, Li Y, Wang W*. Prognostic significance of albumin-bilirubin score in patients with unresectable hepatocellular carcinoma undergoing combined immunotherapy and radiotherapy.,J Med Imaging Radiat Oncol.,doi: 10.1111/1754-9485.13398

Du R#, Ming J#, Geng J#, Zhu X, Zhang Y, Li S, Liu Z, Wang H, Wang Z, Tang L, Zhang X, Wu A, Bu Z, Yan Y, Li Z, Li Y*, Li Z*, Wang W*. Establishment of prognostic models for adenocarcinoma of oesophagogastric junction patients with neoadjuvant chemoradiotherapy: a real-world study.,Radiat Oncol.,2022;17(1):45

王晓航，耿建昊，张丝媛，朱向高，王维虎*. 显微浸润在临床靶体积定义中的研究进展,中华放射肿瘤学杂志,2020;29(9): 809-812

Song M#, Li S#, Zhang Y#, Geng J, Wang H, Zhu X, Li Y, Cai Y*, Wang W*. Is Elective Inguinal or External Iliac Irradiation During Neoadjuvant (Chemo)radiotherapy Necessary for Locally A dvanced Lower Rectal Cancer With Anal Sphincter Invasion? Pract Radiat Oncol. 2022 Mar-Apr;12(2):125-134. doi: 10.1016/j.prro.2021.10.003. Epub 2021 Oct 17. PMID: 34670136.,Pract Radiat Oncol,2022;12(2):125-134

Rong W#, Yu W#, Wang L#, Wu F#, Zhang K#, Chen B, Miao C, Liu L, An S, Tao C, Wang W*, Wu J*. Adjuvant radiotherapy in central hepatocellular carcinoma after narrow-margin hepatectomy: A 10-year real-world evidence,Chin J Cancer Res,2020 Oct 31;32(5):645-653

Wang Liming#, Wang Weihu#, Rong Weiqi#, Li Zhuo, Wu Fan, Liu Yunhe, Zheng Yiling, Zhang Kai, Siqin Tana, Liu Mei, Chen Bo*, Wu Jianxiong*. Postoperative adjuvant treatment strategy for hepatocellular carcinoma with microvascular invasion: a non-randomized interventional clinical study,BMC cancer,20: 614

Zhao Dan, Zheng Baomin, Xiao Shaowen, Liu Weixin, Xu Xiaolong, Yu Huiming, Sun Yan*, Wang Weihu*. Mapping of Regional Failures After Definitive Radiotherapy in Patients with Locally Advanced Cervical Esophageal Carcinoma,Cancer Management and Research,12: 5293-5299

Yi Du, Ruoxi Wang, Haizhen Yue, Yibao Zhang, Hao Wu*, Weihu Wang*. Dose response and stability of silicone-based deformable radiochromic dosimeters (FlexyDos3D) using spectrophotometer and flatbed scanner,Radiation Physics and Chemistry,168: 108574

Xiao-Hang Wang, Liu-Hua Long, Yong Cui, Angela Y. Jia, Xiang-Gao Zhu, Hong-Zhi Wang, Zhi Wang, Chong-Ming Zhan, Zhao-Hai Wang*, Wei-Hu Wang*. MRI-based radiomics model for preoperative prediction of 5-year survival in patients with hepatocellular carcinoma.,British Journal of Cancer,122:978–985

Chen Bo#, Pan Yan#, Xu Xin#, Wu Fan, Zheng Xuan, Chen Si-Ye, Zhao Yu-Ting, Huang Zhou, Cheng Shu-Hui, Liu Jian-Xiang, Wang Wei-Hu*, Li Ye-Xiong*. Inhibition of EPS8L3 suppresses liver cancer progression and enhances efficacy of sorafenib treatment.,Biomedicine & Pharmacotherapy,128: 110284

Li S#, Geng J#, Wang L#, Teng H, Wang Z, Zhu X, Zhang Y, Wang H, Li Y, Cai Y, Wu A*, Wang W*. Effect of Simultaneous Integrated Boost Intensity Modulated Radiation Therapy (SIB-IMRT) and Non-Operative Strategy on Outcomes of Distal Rectal Cancer Patients with Clinically Positive Lateral Pelvic Lymph Node,Cancer management and research,2021; 13: 537-546

Yuan Yidi#, You Jing#, Li Xiaofan*, Wang Weihu*. Adjuvant chemotherapy after radiotherapy or concurrent chemoradiotherapy for pelvic lymph node-positive patients with locally advanced cervical cancer: a propensity score matching analysis,International Journal of Gynecological Cancer,01230

Dong D-Z#, Dong Q-S#, Zhang F-N#, Li C-L, Wang L, Li Y-H, Wang W-H*, Wu A-W. Impact of COVID-19 on treatment modalities and short-term outcomes of rectal cancer following neoadjuvant chemoradiotherapy: a retrospective study,British Journal of Surgery,2021, 1-2

Deng W#, Yang Z#, Dong X, Yu R*, Wang W*. Conditional survival in patients with esophageal or gastroesophageal junction cancer after receiving various treatment modalities,Cancer Medicine,2021;10(2): 659-674

Wang Yujie, Lu Qian*, Zhang Lichun, Zhuang Bing, Zhang Tong, Jin Sanli, Sun Yan, Xiao Shaowen, Zheng Baomin, Fang Yu, Gong Liqing, Wang Yanli, Cao Yiwei, Wang Weihu*. Nutrition Impact Symptom Clusters in Patients With Head and Neck Cancer Receiving Concurrent Chemoradiotherapy,Journal of pain and symptom management,2021

Sui X#, Jiang L#, Teng H, Mi L, Li B, Shi A, Yu R, Li D, Dong X, Yang D, Yu H*, Wang W*. Prediction of Clinical Outcome in Locally Advanced Non-Small Cell Lung Cancer Patients Treated With Chemoradiotherapy by Plasma Markers,Frontiers in Oncology,2021;10: 625911

Li S#, Dong D#, Geng J, Zhu X, Shi C, Zhang Y, Wang H, Zhou S, Wu H, Cai Y, Li Y*, Wang W*. Stereotactic body radiotherapy prolongs the progression-free survival and delays the change of systemic therapy regimen in patients with lung oligoprogressive metastatic colorectal cancer,Asia-Pacific Journal of Clinical Oncology,2021: 13577

Deng W#, Yu R#*, Yang Z#, Dong X, Wang W*. Trends in conditional overall survival of esophageal cancer: a population-based study,Annals of Translational Medicine,2021;9(2): 102

Chen HY#, Feng LL#, Li M#, Ju HQ#, Ding Y#, Lan M#, Song SM, Han WD, Yu L, Wei MB, Pang XL, He F, Liu S, Zheng J, Ma Y, Lin CY, Lan P, Huang MJ, Zou YF, Yang ZL, Wang T, Lang JY, Orangio GR, Poylin V, Ajani JA, Wang WH*, Wan XB*. College of American Pathologists Tumor Regression Grading System for Long-term Outcome in Patients with Locally Advanced Rectal Cancer,The Oncologist,2021: 13707

Wang QX#, Zhang R#, Xiao WW#, Zhang S#, Wei MB, Li YH, Chang H, Xie WH, Li LR, Ding PR, Chen G, Zeng ZF, Wang WH*, Wan XB*, Gao YH*. The watch-and-wait strategy versus surgical resection for rectal cancer patients with a clinical complete response after neoadjuvant chemoradiotherapy,Radiation Oncology,2021;16:16

Wang, L.#, Wang, W.#, Rong, W.#, Li, Z., Wu, F., Liu, Y., Zheng, Y., Zhang, K., Siqin, T., Liu, M.*, Chen, B., & Wu, J*. Postoperative adjuvant treatment strategy for hepatocellular carcinoma with microvascular invasion: a non-randomized interventional clinical study,BMC Cancer,2020; 20(1):614

Li.S#,Zhang.Y#,Yu.Y#,Zhu,X,Geng,J,Teng.H,Wang.Z,Sun.T,Wang.L,Wang.H,Ll.Y,Wu.A,Cai.Y*,Wang.W*,Simultaneous Integrated Boost Intensity-Modulated Radiation Therapy Can Benefit the Locally Advanced Rectal Cancer Patients With Clinically Positive Lateral Pelvic Lymph Node,Frontiers in Oncology,2021;10，627572

Dong.D#,Dong.Q#,Zhang.F#,Li.C#,Wang.L#,Li.Y#,Wang.W*,Wu.A*,Impact of COVID-19 on treatment modalities and short-term outcomes of rectal cancer following neoadjuvant chemoradiotherapy: a retrospective study,British Journal of Surgery,2021,1-2

Deng.W#,Yang.Z#,Dong.X#,Yu.R*,Wang.W*，Conditional survival in patients with esophageal or gastroesophageal junction cancer after receiving various treatment modalities,Cancer Medicine,2021;10(2)，659-674

Wang. Y#,Lu. Q,*,Zhang .L#,Zhuang. B#,Zhang .T#,Jin .S#,Sun.Y#,Xiao.S#,Zheng.B#,Fang.Y#,Gong.L#Wang.Y#,Cao. Y#,Wang.W*,Nutrition Impact Symptom Clusters in Patients With Head and Neck Cancer Receiving Concurrent Chemoradiotherapy,Journal of pain and symptom management,2021,online

Li C#, Li X#, You J#, Liang B, Su X, Huang Y, Chen Y, Hu Q, Deng J, Wang H, Pu Y, Liu H, Ma Y, Wang W*, Wu H*, Zhang Y*. Impact of radiation source activity on short- and long-term outcomes of cervical carcinoma patients treated with high-dose-rate brachytherapy: A retrospective cohort study. Gynecol Oncol,Gynecologic Oncology,020 Nov;159(2)，365-372

You J#,Yang D,Li D,Jiang L,Yu R,Yu H,Xu B,Wang W*,Shang A*,同步推量调强放疗在局部晚期非小细胞肺癌中的应用,中国肺癌杂志,2019年11期,696-701

Huang Z#, Shi M#, Wang W-H#, Shen L-F#, Tang Y, Rong Q-L, Zhu L, Huang X-B, Tie J, Chen J-Y, Zhang J, Wu H-F, Chen J, Liu M, Ma C-Y, Wang S-L*, Li Y-X*. A novel nomogram for predicting locoregional recurrence risk in breast cancer patients treated with neoadjuvant chemotherapy and mastectomy,Radiotherapy and Oncology,2021;161:191-197

Song M#, Wang H#, Wang L, Li S, Zhang Y, Geng J, Zhu X, Li Y*, Cai Y*, Wang W*. Dentate line invasion as a predictive factor of poor distant relapse-free survival in locally advanced lower rectal cancer with anal sphincter involvement.,BMC Cancer,2022;22(1):1196

Xiang Y#, Li S#, Wang H#, Song M, Hu K, Wang F, Wang Z, Niu Z, Liu J, Cai Y, Li Y, Zhu X, Geng J, Zhang Y, Teng H*, Wang W*. MRI-based radiomics to predict neoadjuvant chemoradiotherapy outcomes in locally advanced rectal cancer: A multicenter study.,Clin Transl Radiat Oncol,2022;38:175-182

Shi C, Zhang Y, Li Y, Geng J, Zhu X, Wang H, Cai Y, Wang W. Hyperfractionation versus Conventional Fractionation of Preoperative Intensity-Modulated Radiotherapy with Oral Capecitabine in Locally Advanced Mid-Low Rectal Cancer: A Propensity Score Matching Study.,J Oncol.,2022 Apr 11;2022:9119245.

中国医师协会放射肿瘤治疗医师分会，中华医学会放射肿瘤治疗学分会，中国抗癌协会肿瘤放射治疗专业委员会，王维虎*，曾昭冲*. 中国原发性肝细胞癌放射治疗指南（2020年版）,国际肿瘤学杂志,2021;48(1): 1-10

胸部肿瘤放疗规范和靶区定义, 主编, 中南大学出版社, 2020.3

放射治疗常规, 主编, 中国医药科技出版社, 2020.11

消化系统肿瘤放疗 1. 肝癌精准放疗的靶区和治疗模式研究； 2. 消化系统肿瘤放疗联合靶向和免疫治疗的临床试验及生物标志物探索； 3. 基于人工智能和多模态MRI的影像组学研究； 4. 消化系统肿瘤肠道微生物组学研究； 5. 肝癌放疗敏感性相关基础研究。

门脉癌栓精确放疗临床应用规范的编制与验证, 课题负责人, 2017.1.30～2019.12.31, 科技部

线粒体自噬影响肝细胞肝癌放疗敏感性的分子机制, 课题负责人, 2021.1.1～2024.12.31, 国家自然科学基金

登峰人才计划：肿瘤学, 课题负责人, 2023.1.1～2026.12.31, 北京市医院管理局登峰人才计划

免疫治疗及新型生物治疗-基于肿瘤基因组测序发现的高突变基因为靶点的肿瘤疫苗研究, 参加者, 2016.1.10～2020.12.10, 中国医学科学院医学与健康科技创新工程

免疫肠内营养支持对头颈鳞癌术后放化疗患者口腔黏膜炎的预防效果—— 一项前瞻性队列研究, 课题负责人, 2023.5.1～2024.4.26, CSCO

智慧组学体系建设-结直肠癌数据, 课题负责人, 2019.10.1～2019.12.31, 高精尖学科建设项目

利用人工智能和多模态MRI构建直肠癌术前同步放化疗疗效预测系统, 课题负责人, 2018.7.1～2020.6.30, 院内课题

利用人工智能和多模态MRI构建直肠癌术前同步放化疗疗效预测系统——多中心大样本研究, 课题负责人, 2018.3.1～2021.6.1, 北京市科委首都临床特色应用专项

利用以人工智能技术和多模态MRI为基础的影像组学构建肝癌精准放疗评测系统, 课题负责人, 2018.1.1～2020.12.31, 北京市自然科学基金

基于人工智能技术和多模态影像构建肝细胞肝癌精准放疗评测系统, 课题负责人, 2018.1.1～2020.12.31, 北京市医院管理局临床技术创新项目　扬帆计划